Search Results

You are looking at 91 - 100 of 817 items for :

  • "screening" x
Clear All
Full access

Ivana Espinosa, Christina Pozo- Kaderman, Maritza Alencar, Jessica MacIntyre, Lisa Merheb, Elise James, Abby-Gail Solomon, Michelle Rodriguez Diaz, Sophie Torrents and Maria Rueda- Lara

evaluate the current distress screening process at our HSCT inpatient unit. Methods: At Sylvester Cancer Comprehensive Center, current Psychological Distress Screening Guidelines (PDSG) require social workers to administer a distress screening form within

Full access

Trung Tat Ngo and Le Huu Song

of TERT promoter mutations along with miRNA-122 expression level for screening HBV-related HCC. Methods: Nested PCR assay was optimised for detecting TERT promoter mutations C228T (-124G≥A) and C250T (-146G≥A) directly from patients’ blood. miR122

Full access

Melissa F. Miller, Melyssa Allen, Diane Robinson, Nicole Nicksic and Alexandra Zaleta

Background: The Cancer Support Community (CSC) has investigated screening, referral and follow-up for cancer-related distress through the CancerSupportSource® (CSS) since 2008. The impact of CSS on patient cost and health care utilization at a

Full access

Antonio Di Meglio, Nancy U. Lin, Rachel A. Freedman, William T. Barry, Eric P. Winer and Ines Vaz-Luis

−/HER2−, and very uncommonly with HR+/HER2− breast cancer, had brain metastases on initial staging; of these, 6 were asymptomatic at the time of CNS screening: 5 of 6 and 1 of 6 patients had ≥5 and <5 brain metastases, respectively. Baseline TM testing

Full access

Population Best Practices in Implementation and Use of Clinical Practice Guidelines AB2015-9. Longitudinal Evaluation of a Colorectal Cancer Screening Measurement Model Bryan Loy, MD MBA; William T. Brooks, BS; Michael Yang, MD, MS; Laura E

Full access

Christina Rybak and Michael J. Hall

hereditary nonpolyposis colorectal cancer. Previously, an understanding of the workup of individuals suspected of having LS could be left to those specializing in genetics. Recently, screening of all patients with newly diagnosed CRC for LS independent of

Full access

The February 2012 article by Goulart et al titled, “Lung Cancer Screening With Low-Dose Computed Tomography: Costs, National Expenditures, and Cost-Effectiveness,” (J Natl Compr Canc Netw 2012, doi: 10.6004/jnccn.2012.0023 ) was published with an

Full access

Kathleen N. Moore and Joan L. Walker

and pathologic study of koilocytotic atypia . Ann N Y Acad Sci 1956 ; 63 : 1245 – 1261 . 5 Clavel C Masure M Bory JP . Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932

Full access

Hanna K. Sanoff, YunKyung Chang, Joseph M. Stavas, Til Stürmer and Jennifer Lund

this article at JNCCN.org ). Laboratory parameters were not available, and therefore diagnosis codes for complications of cirrhosis were used to control for confounding liver disease. 24 HCC screening behavior was ascertained based on prediagnosis α

Full access

Deborah J. MacDonald, Kathleen R. Blazer and Jeffrey N. Weitzel

R apidly evolving genetic and genomic technologies for genetic cancer risk assessment (GCRA) are revolutionizing the approach to targeted therapy and cancer screening and prevention, heralding the era of personalized medicine. Although academic